Basic info
Industry
biotechnology research
Sectors
Biotechnology
Life Science
gene therapy
ipsc
start-up
bone marrow failure disease
clinical trials
blood diseases
research and development
Health Care
cell therapy
sickle cell disease
hematologic malignancies
clinical
cell and gene therapy
Therapeutics
hsc
platform
manufacturing
stem cells
cell therapy manufacturing
biotech
beta thalassemia
Date founded
2021
Funding rounds raised
Total raised
$72M
from 11 investors over 11 rounds
G
Garuda Therapeutics raised $62M on February 7, 2023
Investors: Sectoral Asset Management, Northpond Ventures, OrbiMed Advisors and Aisling Capital
G
Garuda Therapeutics raised $72M on September 23, 2021
Investors: Aisling Capital, Sectoral Asset Management, Tatleaux Partners, LLC, Northpond Ventures, Ridgeback Capital Management LLC, Monashee Investment Management LLC and OrbiMed Advisors